Poulam M. Patel

5.6k total citations
86 papers, 3.0k citations indexed

About

Poulam M. Patel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Poulam M. Patel has authored 86 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 36 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Poulam M. Patel's work include Immunotherapy and Immune Responses (25 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Renal cell carcinoma treatment (14 papers). Poulam M. Patel is often cited by papers focused on Immunotherapy and Immune Responses (25 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Renal cell carcinoma treatment (14 papers). Poulam M. Patel collaborates with scholars based in United Kingdom, United States and Germany. Poulam M. Patel's co-authors include Andrew M. Jackson, Peter J. Selby, Rosamonde E. Banks, Stefan Suciu, Alexander M.M. Eggermont, Wim H.J. Kruit, Cornelis J.A. Punt, Sarah L. Young, Hester Franks and Rachel A. Craven and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Poulam M. Patel

84 papers receiving 2.9k citations

Peers

Countries citing papers authored by Poulam M. Patel

Since Specialization

Citations

This map shows the geographic impact of Poulam M. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Poulam M. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Poulam M. Patel more than expected).

Fields of papers citing papers by Poulam M. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Poulam M. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Poulam M. Patel. The network helps show where Poulam M. Patel may publish in the future.

Co-authorship network of co-authors of Poulam M. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Poulam M. Patel. A scholar is included among the top collaborators of Poulam M. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Poulam M. Patel. Poulam M. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunotherapeutic Strategies for Intra-cranial Metastatic Melanoma - a Meta-analysis and Systematic Review 2024 ·Journal of Cancer ·(unknown), Ankit Rao, Christina Peters, (unknown), (unknown), (unknown), Poulam M. Patel	2
2	Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion 2023 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), (unknown), (unknown), Roya Babaei‐Jadidi, (unknown), (unknown), Kiren Yacqub‐Usman, Andrew M. Jackson, Jonathan C. Morris, Poulam M. Patel, David O. Bates	14
3	The prognostic significance of non‐sentinel lymph node metastasis in cutaneous and acral melanoma patients—A multicenter retrospective study 2020 ·Cancer Communications ·Wei Sun, Yu Xu, Jilong Yang, Zhichao Liao, Tao Li, (unknown), Poulam M. Patel, Wangjun Yan, Yong Chen	6
4	Ran GTPase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion 2020 ·Journal of Clinical Pathology ·Somaia Elsheikh, (unknown), (unknown), (unknown), (unknown), (unknown), Teresa P. Raposo, Wakkas Fadhil, Philip S. Rudland, Mohammed A. Aleskandarany, Poulam M. Patel, Mohamed El‐Tanani, Mohammad Ilyas	4
5	Use of Teleconsultations in a Regional Stereotactic Radiosurgery Service: Pilot Study 2019 ·JMIR Formative Research ·(unknown), (unknown), (unknown), (unknown), Poulam M. Patel, (unknown), (unknown)	1
6	The Use of Patient-Facing Teleconsultations in the National Health Service: Scoping Review 2019 ·JMIR Medical Informatics ·(unknown), (unknown), (unknown), Poulam M. Patel, (unknown)	60
7	UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time 2019 ·Urology ·Naveen Vasudev, (unknown), (unknown), Roisean E. Ferguson, Selina Bhattarai, Adebanji Adeyoju, Jon Cartledge, Michael Kimuli, (unknown), Damian Hanbury, David Hrouda, Grenville Oades, Poulam M. Patel, Naeem Soomro, Grant D. Stewart, Mark Sullivan, Jeff Webster, Michael Messenger, Peter J. Selby, Rosamonde E. Banks	12
8	The genetic vulnerability to cisplatin ototoxicity: a systematic review 2019 ·Scientific Reports ·(unknown), (unknown), Niklas K. Edvall, Jan Bulla, Poulam M. Patel, Barbara Canlon, Christopher R. Cederroth, David Baguley	50
9	Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC 2017 ·Annals of Oncology ·Jennifer J. Knox, Carlos H. Barrios, T.M. Kim, Thomas M. Cosgriff, Vichien Srimuninnimit, K. Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, J. Thaddeus Beck, Florence Cheung, (unknown), Poulam M. Patel, Lionnel Geoffrois, Julie Niolat, Noah Berkowitz, Mahtab Marker, (unknown), Robert J. Motzer	84
10	Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials 2014 ·The Lancet Oncology ·Keith T. Flaherty, Michael Hennig, Sandra J. Lee, Paolo A. Ascierto, Reinhard Dummer, Alexander M.M. Eggermont, Axel Hauschild, Richard Kefford, John M. Kirkwood, Georgina V. Long, Paul Lorigan, Andréas Mackensen, Grant A. McArthur, Steven O’Day, Poulam M. Patel, Caroline Robert, Dirk Schadendorf	56
11	A Comparative Study of Adhesion of Melanoma and Breast Cancer Cells to Blood and Lymphatic Endothelium 2012 ·Lymphatic Research and Biology ·Sabreena Safuan, Sarah J. Storr, Poulam M. Patel, Stewart G. Martin	11
12	Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines 2011 ·British Journal of Cancer ·(unknown), (unknown), Charles A. Laughton, Lodewijk V. Dekker, Peter M. Fischer, David M. Wilson, Rachel Abbotts, (unknown), Poulam M. Patel, Ian D. Hickson, Srinivasan Madhusudan	54
13	Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032) 2011 ·European Journal of Cancer ·Poulam M. Patel, Stefan Suciu, Laurent Mortier, Wim H.J. Kruit, Caroline Robert, Dirk Schadendorf, Uwe Trefzer, Cornelis J.A. Punt, Reinhard Dummer, Neville Davidson, Juergen C. Becker, Robert M. Conry, John A. Thompson, Wen-Jen Hwu, (unknown), Sanjiv S. Agarwala, Ulrich Keilholz, Alexander M.M. Eggermont, Alan Spatz	142
14	Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952 2010 ·European Journal of Cancer ·Marna G. Bouwhuis, Stefan Suciu, (unknown), François Salès, Konstantin Stoitchkov, Poulam M. Patel, V. Cocquyt, José Thomas, D. Liénard, A.M.M. Eggermont, G. Ghanem	34
15	Tumour‐mediated disruption of dendritic cell function: Inhibiting the MEK1/2‐p44/42 axis restores IL‐12 production and Th1‐generation 2008 ·International Journal of Cancer ·Andrew M. Jackson, (unknown), Xing Zhu, (unknown), Poulam M. Patel	34
16	Intrinsic chemotherapy resistance to the tubulin‐binding antimitotic agents in renal cell carcinoma 2005 ·International Journal of Cancer ·Roisean E. Ferguson, Sharon M. Jackson, Anthea J. Stanley, Adrian Joyce, Patricia Harnden, Ewan E. Morrison, Poulam M. Patel, Roger M. Phillips, Peter J. Selby, Rosamonde E. Banks	25
17	Identification of proteins regulated by interferon‐α in resistant and sensitive malignant melanoma cell lines 2004 ·PROTEOMICS ·Rachel A. Craven, Anthea J. Stanley, Sarah Hanrahan, Nick Totty, David Jackson, Răzvan Popescu, Allen Taylor, Jürgen Frey, Peter J. Selby, Poulam M. Patel, Rosamonde E. Banks	12
18	The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line 2003 ·Melanoma Research ·David Jackson, Diane Watling, Neil C. Rogers, Rosamonde E. Banks, Ian M. Kerr, Peter J. Selby, Poulam M. Patel	18
19	The response of human dendritic cells to recombinant adenovirus, recombinant Mycobacterium bovis Bacillus Calmette Guerin and biolistic methods of antigen delivery: different induction of contact-dependant and soluble signals 2001 ·Immunology Letters ·Steven G. Smith, Poulam M. Patel, Peter J. Selby, Andrew M. Jackson	17
20	Generation of Interleukin-2-Secreting Melanoma Cell Populations from Resected Metastatic Tumors 1994 ·Human Gene Therapy ·Poulam M. Patel, Claudia L. Flemming, Cyril Fisher, (unknown), J.M. Thomas, Martin Gore, Mary Collins	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact